Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-04 08:30 am Purchase | 2021-05-27 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | Avoro Capital Advisors LLC | 300,000 9.500% | 300,000 (New Position) | Filing History |
| 2021-05-26 5:01 pm Purchase | 2021-05-17 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | Point72 Asset Management, L.P. | 121,667 3.900% | 121,667 (New Position) | Filing History |
| 2021-02-10 3:22 pm Sale | 2021-02-10 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | BML Investment Partners, L.P. | 140,663 4.500% | -12,019 (-7.87%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | The Vanguard Group | 180,772 5.760% | 180,772 (New Position) | Filing History |
| 2021-01-08 9:59 pm Purchase | 2020-09-18 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | Ikarian Capital, LLC | 31,719 1.000% | 31,719 (New Position) | Filing History |
| 2020-11-20 5:31 pm Unchanged | 2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | Satter Muneer A | 374,789 11.900% | 0 (Unchanged) | Filing History |
| 2020-11-12 5:15 pm Purchase | 2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | ORBIMED ADVISORS LLC | 346,263 11.000% | 346,263 (New Position) | Filing History |